On this page
What each program costs in Montana
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
What do Montana's big insurers publish on Wegovy and Zepbound?
Blue Cross and Blue Shield of Montana
Blue Cross and Blue Shield of Montana treats GLP-1 weight-management coverage as an optional choice for employer groups. From November 1, 2026, self-funded groups with Prime Therapeutics that cover these drugs can set a $150 member cost share for up to a 30-day supply.
Blue Cross and Blue Shield of Montana
In a May 20, 2026 note for self-funded groups, Blue Cross and Blue Shield of Montana says GLP-1 weight-management coverage is optional for the plan.
“As with other GLP‑1s for weight management, plan coverage is optional with utilization management and metabolic health programs are available to drive safe and clinically appropriate use.”
https://www.bcbsmt.com/producer/news/05-20-26-new-glp1-coverage-2026 · read Oct 29, 2026
Blue Cross and Blue Shield of Montana
An October 9, 2026 employer notice adds a $150 member cost-share option from November 1, 2026 for self-funded groups that cover these drugs.
“Beginning Nov. 1, 2026, self-funded groups with Prime Therapeutics® that cover GLP-1 weight-management drugs can elect a new, $150 member cost-share benefit.”
https://www.bcbsmt.com/employer/news/10-09-26-greater-flexibility · read Oct 29, 2026
Does Montana Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
Montana's Prescription Drug Program manual lists drugs prescribed for weight reduction as not covered, so Montana Medicaid does not cover Wegovy or Zepbound for weight loss. Read from state documents Nov 6, 2026.
What Montana Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. Montana Department of Public Health and Human Services, Montana Healthcare Programs.
WegovyNo
Drugs prescribed for weight reduction are not covered. DUR Board criteria cover Wegovy for heart risk in adults with cardiovascular disease and for MASH.
“Drugs prescribed: To promote fertility For erectile dysfunction For weight reduction”
Montana DPHHS, Montana Healthcare Programs · No effective date on the document · read Nov 6, 2026
“Reduction of risk of MACE in adults with established CVD and obesity or overweight”
Montana DPHHS, Montana Healthcare Programs · No effective date on the document · read Nov 6, 2026
ZepboundNo
Drugs prescribed for weight reduction are not covered. DUR Board criteria cover Zepbound for obstructive sleep apnea in adults with a BMI of 30 or higher, without type 2 diabetes.
“Drugs prescribed: To promote fertility For erectile dysfunction For weight reduction”
Montana DPHHS, Montana Healthcare Programs · No effective date on the document · read Nov 6, 2026
“Have a diagnosis of obstructive sleep apnea (OSA) with an apnea-hypopnea index (AHI) greater than or equal to 15.”
Montana DPHHS, Montana Healthcare Programs · No effective date on the document · read Nov 6, 2026
OzempicNo
Drugs prescribed for weight reduction are not covered. Ozempic injections are a preferred drug in the diabetes GLP-1 class on the preferred drug list.
“Drugs prescribed: To promote fertility For erectile dysfunction For weight reduction”
Montana DPHHS, Montana Healthcare Programs · No effective date on the document · read Nov 6, 2026
“DIABETES: GLP-1/GIP AND COMBOS”
Montana DPHHS, Montana Healthcare Programs · No effective date on the document · read Nov 6, 2026
MounjaroNo
Drugs prescribed for weight reduction are not covered. Mounjaro is non-preferred in the diabetes GLP-1 class, after a trial of preferred agents.
“Drugs prescribed: To promote fertility For erectile dysfunction For weight reduction”
Montana DPHHS, Montana Healthcare Programs · No effective date on the document · read Nov 6, 2026
“Trial of 2 preferred agents for 6 months each required”
Montana DPHHS, Montana Healthcare Programs · No effective date on the document · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from Montana Department of Public Health and Human Services, Montana Healthcare Programs documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.
Weight loss
Not covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
189 prescriptions
Ozempic and Mounjaro, 2025
18,131 prescriptions
Neighbours covering weight loss
0 of 4
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your Montana Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed Montana Medicaid as "not covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Montana Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Montana Medicaid pay for?
22,719 GLP-1 prescriptions in 2025, 47th of the 50 states and DC, with $22.0 million reimbursed before rebates. Counting the share other payers covered, $22.2 million.
Prescriptions, 2025
22,719
47th of 51
Medicaid paid
$22.0M
44th of 51, before rebates
Per prescription
$967
$1,051 nationally
Weight-loss brands
0.8%
42nd highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Montana is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 0.8% of Montana Medicaid's GLP-1 prescriptions in 2025 (189). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was Montana Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Ozempic | 15,263 | 67% | $14.8 million | $967 |
| Trulicity | 3,638 | 16% | $3.5 million | $950 |
| Mounjaro | 2,868 | 13% | $3.0 million | $1,040 |
| Victoza | 330 | 1.5% | $213,926 | $648 |
| Liraglutide (generic) | 258 | 1.1% | $165,564 | $642 |
| Rybelsus | 161 | 0.7% | $148,665 | $923 |
| Wegovyapproved for weight management | 153 | 0.7% | $200,535 | $1,311 |
| Zepboundapproved for weight management | 36 | 0.2% | $38,542 | $1,071 |
| Bydureon | 12 | 0.1% | $9,845 | $820 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
Which FDA-registered outsourcing facilities are in Montana?
FDA's register of 503B outsourcing facilities, updated Nov 17, 2026, lists 1 in Montana. The register does not say which, if any, supplies a program on this page.
- OSRX, Inc., Missoula. Registered since Oct 28, 2023; last FDA inspection Nov 14, 2025.
On Medicare in Montana?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Montana and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
None of the 4 states next to Montana covers GLP-1s for weight loss through Medicaid. None has a lower cash floor than Montana's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Montana | Not covered | 19 | $39/mo |
| Idaho | Not covered | 19 | $39/moWellmedr |
| North Dakota | Not covered | 17 | $39/moWellmedr |
| South Dakota | Not covered | 19 | $39/moWellmedr |
| Wyoming | Not covered | 19 | $39/moWellmedr |






















